Safety Alert

# Title Type of news Date Link of news
212 Safety Signal of Risankizumab and the Risk of Neutropenia Signal
211 Safety Signal of Sorafenib and the Risk of Multiple Organ Dysfunction Syndrome Signal
210 Safety Signal of Sertraline and the Risk of Cardiac arrest Signal
209 Safety Signal of Furosemide and the Risk of Cellulitis Signal
208 Safety Signal of Tisagenlecleucel and the Risk of Pneumonia Signal
207 Safety Signal of Ertapenem and the Risk of Stevens Johnson syndrome Signal
206 Safety Signal of Prednisolone and the Risk of Respiratory failure Signal
205 Safety Signal of Calcium gluconate and the Risk of Phlebitis Signal
204 Safety Signals Identified by SFDA (April - June) 2025 Signal
203 Safety Signal of Vitamin B complex and the Risk of Dysgeusia Signal
Displaying 11 - 20 of 224